Short Note on Regulation (EU) No 536/2014 on Clinical Trials
Regulation (EU) No 536/2014, enacted by the European Parliament and the Council on April 16, 2014, provides a comprehensive framework for the conduct of clinical trials on medicinal products for human use within the EU. It aims to ensure the protection of participants’ rights, safety, and well-being while facilitating the efficient and ethical conduct of […]
The EU Decentralised Clinical Trials Project: Revolutionizing Clinical Research
Background The landscape of clinical trials in the European Union (EU) is evolving, driven by the need for innovative trial designs and methodologies that address both emerging opportunities and inherent challenges. The EU Decentralised Clinical Trials (DCT) project is a pioneering initiative aimed at transforming the traditional clinical trial framework to enhance accessibility and convenience […]
Advanced therapy medicinal products (ATMPs)
Advanced therapy medicinal products (ATMPs) What are ATMPs? Advanced therapy medicinal products (ATMPs) are a new and innovative type of medicine that uses genes, tissues, or cells to treat or prevent diseases. They work by repairing, replacing, or supplementing damaged or diseased cells and tissues. ATMPs can be used to treat a wide range of […]
Adaptive Pathways for Medicine Development
Adaptive pathways is an approach to medicine development that is based on iterative development, confirming benefit-risk balance, and gathering real world data. It applies to treatments in areas of high medical need. The European Medicines Agency (EMA) defines adaptive pathways as a flexible approach to clinical trial design, data analysis, and regulatory review that allows […]
FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies
FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies: The FDA is investigating reports of T-cell malignancies, including CAR-positive lymphoma, in patients treated with BCMA- or CD19-directed autologous CAR T cell immunotherapies. These reports stem from both clinical trials and postmarketing data. All currently approved […]
Electronic submission of medicinal product information by marketing-authorisation holders
Electronic submission of medicinal product information by marketing-authorisation holders In the dynamic landscape of pharmaceutical regulation, the European Union (EU) stands at the forefront of ensuring the safety and efficacy of medicinal products. One pivotal aspect of this regulatory framework is the submission of comprehensive product information by marketing-authorisation holders (MAHs). Traditionally, this process involved extensive paperwork, […]
Ensuring Safety and Effectiveness in Stress Urinary Incontinence Treatment: FDA Guidelines and Recommendations
Ensuring Safety and Effectiveness in Stress Urinary Incontinence Treatment: FDA Guidelines and Recommendations Stress Urinary Incontinence (SUI) affects millions of women worldwide, impacting their quality of life significantly. Surgical mesh sling procedures have been a common approach to address this condition. However, concerns regarding the safety and effectiveness of these procedures have prompted regulatory scrutiny, […]
FDA Approves Consent Decree Addressing Philips Respironics CPAP and BiPAP Recall
The U.S. District Court for the Western District of Pennsylvania has approved a consent decree of permanent injunction against Philips Respironics and associated entities, along with individual defendants, including the CEO of Royal Philips. This decree restricts the production and sale of new CPAP and BiPAP machines at certain Philips Respironics facilities in the U.S. […]
FDA Approves Zevtera for Serious Bacterial Infections!
FDA Approves Zevtera for Serious Bacterial Infections! Great news on the healthcare front! The U.S. Food and Drug Administration has just given the green light to Zevtera (ceftobiprole medocaril sodium for injection), marking a significant breakthrough in the battle against serious bacterial infections. Zevtera is now cleared for use in adults facing challenging conditions like […]